Clinical Relevant Oncogenic Drivers in Advanced Adenocarcinoma Discloses New Therapeutic Targets in Negative EGFR/ALK/KRAS Patients

Resumo

Descrição

Palavras-chave

non-smallc ell lung cancer, advanced lung cancer, mutations, next generation sequencing

Como citar

Journal Of Thoracic Oncology. New York: Elsevier Science Inc, v. 12, n. 1, p. S955-S955, 2017.